Since 2000, LRAAC has conducted research for new treatments for allergies and asthma. In our 17 years we have completed over 150 clinical trials. If you would like to contact us regarding information about current clinical trials at LRAAC, call Mindy DeMarco RN,BSN,CCRP at 501-224-1156 Option 7.

Novartis CQGE031C2201E1: Adults with Chronic Urticaria

In follow up- completed enrollment 4/2017

Stallergenes : House Dust Mite Allergy Oral Immunotherapy

In follow up- completed enrollment 5/2017

CAPSTONE 2: Influenza Treatment in High Risk Flu Patients

On hold until 2017/2018 flu season

GSK 205715: Adults 18+ with Inadequately Controlled Asthma, 9 Visits over 13 Months, Compensation up to $1235

Updated 6-20-17

CSP-07-000034: Adults 18+ with Asthma, 3 Visits over 2 Months, Compensation up to $490

Updated 6-20-17

GSK 114971: Males 5-8 and Females 5-7 with Asthma, 20 Visits over 16 months, Compensation up to $1100

Updated 6-20-17

TEVA FSS-AS-30003: Patients 4-11 with Persistent Asthma, 9 Visits over 12 Weeks, Compensation up to $450

Updated 6-20-17